Scholars Central

Conference abstract

Endothelial progenitor cell biology in Psoriatic Arthritis patients in the absence of traditional cardiovascular risk

Authors: Inderjeet Verma, Ashit Syngle, Pawan Krishan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Endothelial progenitor cells (EPCs) restore dysfunctional endothelium and protect against atherosclerotic vascular disease. Previously EPC population has been assessed in a heterogeneous population of with equivocal results in psoriatic arthritis (PsA) patients with confounding factors. The aim of this study was to investigate EPC population in PsA patients in the absence of traditional cardiovascular risk. Methods: Twenty two patients with PsA according to Classification Criteria for PsA criteria and twenty age- and sexmatched controls were included. Patients with risk factors for cardiovascular disease were excluded. EPCs (CD34+/CD133+) were assessed by Flow Cytometry. Endothelial function was assessed by measuring endothelial-dependent flow-mediated vasodilatation (FMD %) and carotid intima-media thickness (CIMT) was assessed by ultrasonography. Inflammatory markers i.e. erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tissue necrosis factor (TNF)-α, interleukin (IL)-6, IL-1 were also assessed in all subjects. Results: There was a significant impairment of EPC% in PsA patients as compared to controls (mean 0.028% vs. 0.047%, P<0.001). Endothelial function (FMD) and inflammatory markers were also significantly (P<0.05) altered as compared to healthy controls, but there was no significant difference in CIMT (mean 0.65 vs. 0.56, P=0.06). Specifically, CD34+CD133+cells were positively correlated with FMD (r=-0.62, p=0.004) and negatively correlated with CRP (r=-0.63, p=0.003), TNF-α (r=- 0.58, p=0.008), IL-6 (r=-0.64, p=0.003), disease activity (Disease Activity Score using 28 joints (r=-0.61, p=0.003) and disease activity index for psoriatic arthritis (r=-0.50, p=0.02). Conclusion: There is depleted EPC population in PsA patients in the absence of traditional cardiovascular risk. Inflammation plays a key role in EPC depletion and the later endothelial dysfunction in PsA patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Inderjeet Verma”
  • BylineArticles whose byline prints “Ashit Syngle”
  • BylineArticles whose byline prints “Pawan Krishan”